Omar N. Ammash

Associate

Chicago
omar.ammash@lw.com
+1.312.777.7149

PRACTICES

  • Emerging Companies & Growth
  • Mergers & Acquisitions

BAR QUALIFICATIONS

  • Illinois

EDUCATION

  • J.D., University of Chicago, 2017
  • BA in Political Science, University of Minnesota, 2013
    summa cum laude

PROFILE

Omar Ammash represents US and international-based startups, emerging growth companies, and venture capital investors involved in technology, life sciences, and other growth industries.

Omar advises clients on a full range of transactions and general corporate matters, including:

  • Venture capital financings
  • Corporate governance
  • Mergers and acquisitions
  • Day-to-day corporate advice
  • Early-stage formation and strategy

While attending law school, he was a member of the Corporate Lab, a transactional-focused clinic, working on cutting-edge projects with multinational companies.

EXPERIENCE

Representative transactions include:

Startup and Emerging Growth Company Financings

  • Rivian on multiple venture capital financings 
  • Celestial AI on multiple venture capital financings
  • Sleeper on its US$50m Series C fundraise
  • GT Medical Technologies on its Series C fundraise
  • Novasenta on multiple venture capital financings
  • Homie Technology on multiple venture capital financings 
  • Fluid Truck on its Series B fundraise 
  • Jetti Resources on multiple venture capital financings
  • ActiveCampaign on its US$240 million Series C financing

Venture Capital Investments

  • Goldman Sachs on various lead investments, including in Nested Therapeutics and TORL Biotherapeutics
  • DNS Capital on various lead investments and follow-on growth financings for its portfolio companies
  • Drive Capital on various lead investments and follow-on growth financings for its portfolio companies 
  • GreatPoint Ventures on various lead investments and follow-on growth financings for its portfolio companies
  • Sea Capital in its investment in Forte’s US$725m Series B round 
  • Cadence Design Systems in multiple strategic investments
  • Softbank on various lead investments, including in Forward Health, Sprout Therapy and M1 Finance

Mergers, Acquisitions, and Capital Markets Transactions

  • Tegus on its acquisition of Canalyst
  • GTCR on its sale of Inteliquent to Sinch
  • Castle Creek on multiple portfolio company acquisitions, including its acquisition of Novavita 
  • Henkel on its acquisition of Momentive’s consumer sealants division
  • Blaize on its business combination with BurTech Acquisition Corp.
  • Oscar Health on its US$1.4 billion IPO
  • Aon on its US$80 billion merger of equals with Willis towers (terminated)
  • Carlyle on its acquisition of Apollo Aviation